Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota and microbiome in schizophrenia
Jerzy Samochowiec, Błażej Misiak
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 5, pp. 503-507
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Associations of gut microbiota alterations with clinical, metabolic, and immune-inflammatory characteristics of chronic schizophrenia
Błażej Misiak, Edyta Pawlak, Krzysztof P. Rembacz, et al.
Journal of Psychiatric Research (2024) Vol. 171, pp. 152-160
Closed Access | Times Cited: 25
Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials
Carlos Ribera, Joan Vicent Sánchez‐Ortí, Gerard Clarke, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 158, pp. 105561-105561
Open Access | Times Cited: 21
The current state of research for psychobiotics use in the management of psychiatric disorders–A systematic literature review
Octavian Vasiliu
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 22
MO-GCN: A multi-omics graph convolutional network for discriminative analysis of schizophrenia
Haiyuan Wang, Runlin Peng, Yuanyuan Huang, et al.
Brain Research Bulletin (2025) Vol. 221, pp. 111199-111199
Open Access | Times Cited: 1
Altered gut microbiota and its metabolites correlate with plasma cytokines in schizophrenia inpatients with aggression
Hongxin Deng, Lei He, Chong Wang, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 24
Gut microbiota alterations in schizophrenia might be related to stress exposure: Findings from the machine learning analysis
Paweł Karpiński, Paulina Żebrowska-Różańska, Dorota Kujawa, et al.
Psychoneuroendocrinology (2023) Vol. 155, pp. 106335-106335
Open Access | Times Cited: 15
Interplay between Phytochemicals and the Colonic Microbiota
Chohee Kwon, Meran Keshawa Ediriweera, Somi Kim Cho
Nutrients (2023) Vol. 15, Iss. 8, pp. 1989-1989
Open Access | Times Cited: 14
Profiling gut microbiota signatures associated with the deficit subtype of schizophrenia: Findings from a case-control study
Krzysztof Kowalski, Paulina Żebrowska-Różańska, Paweł Karpiński, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 127, pp. 110834-110834
Closed Access | Times Cited: 13
The brain-gut microbiota network (BGMN) is correlated with symptom severity and neurocognition in patients with schizophrenia
Runlin Peng, Wei Wang, Liqin Liang, et al.
NeuroImage (2025), pp. 121052-121052
Open Access
Dysbiosis and Metabolic Dysregulation of Salivary Microbiota in Schizophrenia
Jie Wang, Lin Lü, Luwen Ren, et al.
Journal of Multidisciplinary Healthcare (2025) Vol. Volume 18, pp. 813-825
Open Access
Treatments for weight gain in schizophrenia
Igor Elman
Current Opinion in Psychiatry (2025)
Closed Access
Altered oral health and microbiota in drug-free patients with schizophrenia
Hua‐Wei Huang, Nai-yan Yang, Mianmian Chen, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Schizophrenia as metabolic disease. What are the causes?
Ahmed Mohamed Helaly, Doaa S. Ghorab
Metabolic Brain Disease (2023) Vol. 38, Iss. 3, pp. 795-804
Open Access | Times Cited: 10
Small fish, big discoveries: zebrafish shed light on microbial biomarkers for neuro-immune-cardiovascular health
Hemaa Sree Kumar, Alexander Wisner, Jeanine M. Refsnider, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 9
16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms
Yihuan Chen, Huan Yu, Fen Xue, et al.
Brain and Behavior (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 3
Bipolar disorder and the gut microbiota: a bibliometric analysis
Xiaoxiao Lin, Jinyu Huang, Shuai Wang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
The emerging roles of microbiota-derived extracellular vesicles in psychiatric disorders
Chuang Guo, Bai Yulong, Pengfei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Gut microbiota alterations in stable outpatients with schizophrenia: findings from a case–control study
Błażej Misiak, Patryk Piotrowski, Agnieszka Cyran, et al.
Acta Neuropsychiatrica (2022) Vol. 35, Iss. 3, pp. 147-155
Open Access | Times Cited: 12
Gut microbiome in intracranial aneurysm growth, subarachnoid hemorrhage, and cerebral vasospasm: a systematic review with a narrative synthesis
Tomasz Klepinowski, Karolina Skonieczna‐Żydecka, Bartłomiej Pala, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 5
Stress, Environment and Early Psychosis
Lida‐Alkisti Xenaki, Stefanos Dimitrakopoulos, Mirjana Selaković, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 437-460
Open Access | Times Cited: 4
The evolutionarily ancient FOXA transcription factors shape the murine gut microbiome via control of epithelial glycosylation
Avital Swisa, Julia E. Kieckhaefer, Scott G. Daniel, et al.
Developmental Cell (2024) Vol. 59, Iss. 16, pp. 2069-2084.e8
Closed Access | Times Cited: 1
Analysis of Intestinal Microbiota in Schizophrenic Patients with Type 2 Diabetes Mellitus
Nan Wang, Chunlei Yin, Ruiqi Feng, et al.
ALPHA PSYCHIATRY (2024) Vol. 25, Iss. 3, pp. 375-381
Open Access | Times Cited: 1
Effects of low-frequency rTMS combined with risperidone on the gut microbiome in hospitalized patients with chronic schizophrenia
Rui Li, Rui Fu, Zhi-quan Cui, et al.
Brain Research (2023) Vol. 1819, pp. 148539-148539
Closed Access | Times Cited: 3
Can bugs be an alternative or adjuvant to drugs in schizophrenia?
Mushraf Syed, Veena Nayak, Padmaja A. Shenoy
Journal of Applied Pharmaceutical Science (2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top